Financial Contrast: Shoulder Innovations (SI) vs. Its Rivals

Shoulder Innovations (NYSE:SI) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare Shoulder Innovations to similar businesses based on the strength of its valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.

Risk & Volatility

Shoulder Innovations has a beta of -1.51, indicating that its stock price is 251% less volatile than the S&P 500. Comparatively, Shoulder Innovations’ competitors have a beta of 2.58, indicating that their average stock price is 158% more volatile than the S&P 500.

Valuation and Earnings

This table compares Shoulder Innovations and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Shoulder Innovations	$47.32 million	-$40.36 million	-12.76
Shoulder Innovations Competitors	$1.89 billion	$136.85 million	5.94

Shoulder Innovations’ competitors have higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings for Shoulder Innovations and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1	0	5	0	2.67
Shoulder Innovations Competitors	4301	10595	18375	836	2.46

Shoulder Innovations presently has a consensus target price of $25.75, suggesting a potential upside of 24.58%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.32%. Given Shoulder Innovations’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Shoulder Innovations is more favorable than its competitors.

Profitability

This table compares Shoulder Innovations and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-51.72%	-25.37%	-20.87%
Shoulder Innovations Competitors	-300.62%	-179.55%	-22.71%

Institutional and Insider Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Shoulder Innovations beats its competitors on 7 of the 12 factors compared.

Shoulder Innovations Company Profile

Shoulder Innovations, Inc. is a medical technology company focused on developing and commercializing products for shoulder replacement surgery. Its offerings are designed for orthopedic surgeons treating patients with shoulder conditions that may require joint replacement. The company’s product portfolio includes shoulder implant systems such as its InSet glenoid and Catalyst reverse shoulder technologies, along with related surgical instruments. These products support different approaches to shoulder arthroplasty, including procedures that replace or reconstruct parts of the shoulder joint.